These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23372791)

  • 1. A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer.
    Curtis VF; Wang H; Yang P; McLendon RE; Li X; Zhou QY; Wang XF
    PLoS One; 2013; 8(1):e54916. PubMed ID: 23372791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy.
    Hasnis E; Alishekevitz D; Gingis-Veltski S; Bril R; Fremder E; Voloshin T; Raviv Z; Karban A; Shaked Y
    Neoplasia; 2014 Jun; 16(6):501-10. PubMed ID: 24957319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
    Shojaei F; Wu X; Zhong C; Yu L; Liang XH; Yao J; Blanchard D; Bais C; Peale FV; van Bruggen N; Ho C; Ross J; Tan M; Carano RA; Meng YG; Ferrara N
    Nature; 2007 Dec; 450(7171):825-31. PubMed ID: 18064003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokineticin 2 antagonist, PKRA7 suppresses arthritis in mice with collagen-induced arthritis.
    Ito H; Noda K; Yoshida K; Otani K; Yoshiga M; Oto Y; Saito S; Kurosaka D
    BMC Musculoskelet Disord; 2016 Sep; 17(1):387. PubMed ID: 27609223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
    Lu R; Kujawski M; Pan H; Shively JE
    Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression.
    Shojaei F; Singh M; Thompson JD; Ferrara N
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2640-5. PubMed ID: 18268320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.
    Monnier J; Piquet-Pellorce C; Feige JJ; Musso O; Clement B; Turlin B; Theret N; Samson M
    World J Gastroenterol; 2008 Feb; 14(8):1182-91. PubMed ID: 18300343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.
    Xin H; Lu R; Lee H; Zhang W; Zhang C; Deng J; Liu Y; Shen S; Wagner KU; Forman S; Jove R; Yu H
    J Biol Chem; 2013 May; 288(19):13842-9. PubMed ID: 23548897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis.
    Zonneville J; Colligan S; Grant S; Miller A; Wallace P; Abrams SI; Bakin AV
    Int J Cancer; 2020 Oct; 147(8):2279-2292. PubMed ID: 32452014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt-1 signaling in macrophages promotes glioma growth in vivo.
    Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
    Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
    He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
    Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer.
    Wang Z; Song W; Aboukameel A; Mohammad M; Wang G; Banerjee S; Kong D; Wang S; Sarkar FH; Mohammad RM
    Int J Cancer; 2008 Aug; 123(4):958-66. PubMed ID: 18528859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bv8 mediates myeloid cell migration and enhances malignancy of colorectal cancer.
    Li X; Chang E; Cui J; Zhao H; Hu C; O'Dea KP; Tirlapur N; Balboni G; Zhang J; Ying L; Ma D
    Front Immunol; 2023; 14():1158045. PubMed ID: 37090721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
    Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
    Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
    Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
    EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.
    Giannini E; Lattanzi R; Nicotra A; Campese AF; Grazioli P; Screpanti I; Balboni G; Salvadori S; Sacerdote P; Negri L
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14646-51. PubMed ID: 19667192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
    Taeger J; Moser C; Hellerbrand C; Mycielska ME; Glockzin G; Schlitt HJ; Geissler EK; Stoeltzing O; Lang SA
    Mol Cancer Ther; 2011 Nov; 10(11):2157-67. PubMed ID: 21885862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.